Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Peringkat dalam Saham #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Harga Saham
$70.50
Terakhir disinkronkan: 2025-11-14
Kapitalisasi Pasar
$7.33B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
116.32%
Negara
US
Perdagangan Metsera, Inc. (MTSR)

Kategori

Riwayat pemecahan saham untuk Metsera, Inc. (MTSR)
Saham Metsera, Inc. (simbol: MTSR) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 25, 2026.
Satu lembar saham MTSR yang dibeli sebelum Aug 25, 2026 sekarang setara dengan 0 lembar saham MTSR.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH